Jaguar Health Inc
JAGX1.860USD
-0.050-2.62%
收盘 09/19, 16:00（美东）报价延迟15分钟
2.85M总市值
亏损市盈率 TTM
关于 Jaguar Health Inc 公司
Jaguar Health, Inc. 是一家商业阶段的制药公司。该公司专注于开发可持续地从雨林地区植物中提取的新型专利处方药，用于治疗患有胃肠道不适的人和动物。该公司通过两个部门运营：人类健康和动物健康。动物健康部门专注于开发和商业化伴侣动物和生产动物的处方和非处方产品。人类健康部门专注于开发和商业化人类产品以及持续商业化 Mytesi，Mytesi 用于缓解接受抗逆转录病毒治疗的人类免疫缺陷病毒 (HIV)/获得性免疫缺陷综合征 (AIDS) 成人患者的非感染性腹泻症状。Canalevia-CA1 用于治疗狗的化疗引起的腹泻 (CID)。其子公司 Napo Pharmaceuticals, Inc. 专注于开发和商业化人类处方药。
公司简介
公司代码JAGX
公司名称Jaguar Health Inc
上市日期May 13, 2015
CEOMs. Lisa A. Conte
员工数量49
证券类型Ordinary Share
年结日May 13
公司地址200 Pine Street Suite 400
城市SAN FRANCISCO
上市交易所NASDAQ Capital Market Consolidated
国家United States of America
邮编94104
电话14153718300
网址https://jaguar.health/
公司代码JAGX
上市日期May 13, 2015
CEOMs. Lisa A. Conte
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Pravin R. Chaturvedi, Ph.D.
Dr. Pravin R. Chaturvedi, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
137.00
+98.55%
Mr. Jonathan S. Wolin
Mr. Jonathan S. Wolin
Chief of Staff, General Counsel, Chief Compliance Officer
Chief of Staff, General Counsel, Chief Compliance Officer
132.00
+100.00%
Mr. Jonathan B. Siegel
Mr. Jonathan B. Siegel
Independent Director
Independent Director
45.00
--
Mr. John J. Micek, III
Mr. John J. Micek, III
Independent Director
Independent Director
--
--
Ms. Carol R. Lizak
Ms. Carol R. Lizak
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Steven R. King, Ph.D.
Dr. Steven R. King, Ph.D.
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property, Secretary
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property, Secretary
--
--
Dr. Anula K. Jayasuriya, M.D., Ph.D.
Dr. Anula K. Jayasuriya, M.D., Ph.D.
Independent Director
Independent Director
--
--
Mr. Ian Wendt
Mr. Ian Wendt
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Lisa A. Conte
Ms. Lisa A. Conte
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. James J. Bochnowski
Mr. James J. Bochnowski
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Pravin R. Chaturvedi, Ph.D.
Dr. Pravin R. Chaturvedi, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
137.00
+98.55%
Mr. Jonathan S. Wolin
Mr. Jonathan S. Wolin
Chief of Staff, General Counsel, Chief Compliance Officer
Chief of Staff, General Counsel, Chief Compliance Officer
132.00
+100.00%
Mr. Jonathan B. Siegel
Mr. Jonathan B. Siegel
Independent Director
Independent Director
45.00
--
Mr. John J. Micek, III
Mr. John J. Micek, III
Independent Director
Independent Director
--
--
Ms. Carol R. Lizak
Ms. Carol R. Lizak
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Steven R. King, Ph.D.
Dr. Steven R. King, Ph.D.
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property, Secretary
Chief of Sustainable Supply, Ethnobotanical Research and Intellectual Property, Secretary
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 9月3日 周三
更新时间: 9月3日 周三
持股股东
股东类型
持股股东
持股股东
占比
Lincoln Alternative Strategies LLC
27.59%
Streeterville Capital LLC
2.09%
Iliad Research & Trading, L.P.
1.46%
Intracoastal Capital, L.L.C.
1.24%
UBS Financial Services, Inc.
0.58%
其他
67.03%
持股股东
持股股东
占比
Lincoln Alternative Strategies LLC
27.59%
Streeterville Capital LLC
2.09%
Iliad Research & Trading, L.P.
1.46%
Intracoastal Capital, L.L.C.
1.24%
UBS Financial Services, Inc.
0.58%
其他
67.03%
股东类型
持股股东
占比
Corporation
32.38%
Investment Advisor
0.62%
Hedge Fund
0.07%
Individual Investor
0.06%
其他
66.87%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
46
243.00K
13.10%
+147.33K
2025Q1
51
102.25K
9.10%
+15.99K
2024Q4
58
1.15M
16.97%
+379.12K
2024Q3
61
1.40M
25.15%
+578.82K
2024Q2
62
807.73K
26.56%
+336.48K
2024Q1
65
210.88K
23.56%
+139.83K
2023Q4
66
157.05K
30.73%
+119.23K
2023Q3
72
88.91K
41.12%
+74.12K
2023Q2
76
63.74K
33.22%
+52.52K
2023Q1
81
10.86K
23.83%
+3.44K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Streeterville Capital LLC
45.48K
3.43%
+35.18K
+341.53%
May 08, 2025
Iliad Research & Trading, L.P.
31.83K
2.4%
+16.08K
+102.12%
Jul 18, 2024
Intracoastal Capital, L.L.C.
27.00K
2.04%
+27.00K
--
May 27, 2025
UBS Financial Services, Inc.
4.32K
0.59%
+2.29K
+112.98%
Mar 31, 2025
RBC Dominion Securities, Inc.
702.00
0.05%
+702.00
--
Mar 31, 2025
Conte (Lisa A.)
133.00
0.01%
+2.00
+1.53%
May 17, 2025
SBI Securities Co., Ltd.
20.00
0%
+16.00
+400.00%
Mar 31, 2025
King (Steven R. Ph.D.)
54.00
0.01%
+1.00
+1.89%
May 17, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Mar 18, 2025
Merger
25→1
Mar 18, 2025
Merger
25→1
Mar 18, 2025
Merger
25→1
Mar 18, 2025
Merger
25→1
May 20, 2024
Merger
60→1
May 20, 2024
Merger
60→1
公告日期
类型
比率
Mar 18, 2025
Merger
25→1
Mar 18, 2025
Merger
25→1
Mar 18, 2025
Merger
25→1
Mar 18, 2025
Merger
25→1
May 20, 2024
Merger
60→1
May 20, 2024
Merger
60→1
May 20, 2024
Merger
60→1
May 20, 2024
Merger
60→1
Jan 20, 2023
Merger
75→1
Jan 20, 2023
Merger
75→1
查看更多
